Better regulation of hormone-disrupting chemicals linked to breast cancer, reproductive problems and other ill-effects could deliver massive cost savings, a report has concluded. The Health and Environment Alliance (HEAL) says exposure to endocrine disrupting chemicals (EDCs) may be costing up to €31 billion (£24.8bn) per year across the European Union (EU) and said the EU should set out a specific timetable by which EDCs must be identified and replaced with safer alternatives.
